Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Circulating tumor cells in patients with testicular germ cell tumors.

Nastały P, Ruf C, Becker P, Bednarz-Knoll N, Stoupiec M, Kavsur R, Isbarn H, Matthies C, Wagner W, Höppner D, Fisch M, Bokemeyer C, Ahyai S, Honecker F, Riethdorf S, Pantel K.

Clin Cancer Res. 2014 Jul 15;20(14):3830-41. doi: 10.1158/1078-0432.CCR-13-2819. Epub 2014 Mar 14.

2.

A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients.

Kim SJ, Masago A, Tamaki Y, Akazawa K, Tsukamoto F, Sato J, Ozawa T, Tsujino Y, Noguchi S.

Breast Cancer Res Treat. 2011 Aug;128(3):765-73. doi: 10.1007/s10549-011-1603-2. Epub 2011 Jun 1.

PMID:
21630023
4.

Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.

Gröbe A, Blessmann M, Hanken H, Friedrich RE, Schön G, Wikner J, Effenberger KE, Kluwe L, Heiland M, Pantel K, Riethdorf S.

Clin Cancer Res. 2014 Jan 15;20(2):425-33. doi: 10.1158/1078-0432.CCR-13-1101. Epub 2013 Nov 11.

6.

[Studies on nuclear DNA content in testicular germ cell tumors using flow cytometry].

Kashiwagi A.

Hokkaido Igaku Zasshi. 1992 Nov;67(6):801-14. Japanese.

PMID:
1336479
7.

Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients.

Liu JF, Kindelberger D, Doyle C, Lowe A, Barry WT, Matulonis UA.

Gynecol Oncol. 2013 Nov;131(2):352-6. doi: 10.1016/j.ygyno.2013.08.006. Epub 2013 Aug 13.

PMID:
23954902
8.
9.

"Somatic-type" malignancies arising from testicular germ cell tumors: a clinicopathologic study of 124 cases with emphasis on glandular tumors supporting frequent yolk sac tumor origin.

Magers MJ, Kao CS, Cole CD, Rice KR, Foster RS, Einhorn LH, Ulbright TM.

Am J Surg Pathol. 2014 Oct;38(10):1396-409. doi: 10.1097/PAS.0000000000000262.

PMID:
24921638
10.

SALL4 is a novel diagnostic marker for testicular germ cell tumors.

Cao D, Li J, Guo CC, Allan RW, Humphrey PA.

Am J Surg Pathol. 2009 Jul;33(7):1065-77. doi: 10.1097/PAS.0b013e3181a13eef.

PMID:
19390421
11.

Outcome of patients with stage II and III nonseminomatous germ cell tumors: results of a single center.

Ataergin S, Ozet A, Arpaci F, Kilic S, Beyzadeoglu M, Komurcu S.

Indian J Cancer. 2007 Jan-Mar;44(1):6-11.

12.

Modified neck dissection for metastatic nonseminomatous testicular carcinoma.

Weisberger EC, McBride LC.

Laryngoscope. 1999 Aug;109(8):1241-4.

PMID:
10443827
13.

Capture of viable circulating tumor cells in the liver of colorectal cancer patients.

Denève E, Riethdorf S, Ramos J, Nocca D, Coffy A, Daurès JP, Maudelonde T, Fabre JM, Pantel K, Alix-Panabières C.

Clin Chem. 2013 Sep;59(9):1384-92. doi: 10.1373/clinchem.2013.202846. Epub 2013 May 21.

14.

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.

Mostert B, Kraan J, Bolt-de Vries J, van der Spoel P, Sieuwerts AM, Schutte M, Timmermans AM, Foekens R, Martens JW, Gratama JW, Foekens JA, Sleijfer S.

Breast Cancer Res Treat. 2011 May;127(1):33-41. doi: 10.1007/s10549-010-0879-y. Epub 2010 Apr 9.

PMID:
20379845
15.

Protein overexpression and gene amplification of epidermal growth factor receptor in adult testicular germ cell tumors: potential role in tumor progression.

Miyai K, Yamamoto S, Asano T, Tamai S, Matsubara O, Tsuda H.

Cancer Sci. 2010 Sep;101(9):1970-6. doi: 10.1111/j.1349-7006.2010.01638.x.

16.

Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.

Wendel M, Bazhenova L, Boshuizen R, Kolatkar A, Honnatti M, Cho EH, Marrinucci D, Sandhu A, Perricone A, Thistlethwaite P, Bethel K, Nieva J, Heuvel Mv, Kuhn P.

Phys Biol. 2012 Feb;9(1):016005. doi: 10.1088/1478-3967/9/1/016005. Epub 2012 Feb 3.

17.

Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.

Hou JM, Krebs MG, Lancashire L, Sloane R, Backen A, Swain RK, Priest LJ, Greystoke A, Zhou C, Morris K, Ward T, Blackhall FH, Dive C.

J Clin Oncol. 2012 Feb 10;30(5):525-32. doi: 10.1200/JCO.2010.33.3716. Epub 2012 Jan 17.

PMID:
22253462
18.

Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques.

Kaifi JT, Kunkel M, Das A, Harouaka RA, Dicker DT, Li G, Zhu J, Clawson GA, Yang Z, Reed MF, Gusani NJ, Kimchi ET, Staveley-O'Carroll KF, Zheng SY, El-Deiry WS.

Cancer Biol Ther. 2015;16(5):699-708. doi: 10.1080/15384047.2015.1030556.

19.

Differential methylation of the OCT3/4 upstream region in primary human testicular germ cell tumors.

De Jong J, Weeda S, Gillis AJ, Oosterhuis JW, Looijenga LH.

Oncol Rep. 2007 Jul;18(1):127-32.

PMID:
17549357
20.

Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.

Divella R, Daniele A, Savino E, Palma F, Bellizzi A, Giotta F, Simone G, Lioce M, Quaranta M, Paradiso A, Mazzocca A.

Anticancer Res. 2013 Apr;33(4):1491-7.

PMID:
23564790

Supplemental Content

Support Center